PHINIA INC. (PHIN) Spending and interest coverage
- R&D / revenue · 12 months: Value 3.02%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.61%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 3.02% | Research and development expense / revenue. Period ending 2026-06-30. $109.00M ÷ $3.62B × 100 ≈ 3.02% |
| Stock-based compensation / revenue · 12 months | 0.61% | Share-based compensation / revenue. Period ending 2026-06-30. $22.00M ÷ $3.62B × 100 ≈ 0.61% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 109.00M USD | Research and Development Expense |
| Revenue | 3.62B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 22.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 252.00M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $109.00M | $3.62B | $22.00M | $252.00M | (m) | 3.02% | 0.61% | (m) | (m) |
| 2026-03-31 | $106.00M | $3.56B | $19.00M | $261.00M | (m) | 2.97% | 0.53% | (m) | (m) |
| 2025-12-31 | $105.00M | $3.48B | $18.00M | $254.00M | (m) | 3.01% | 0.52% | (m) | (m) |
| 2025-09-30 | $107.00M | $3.43B | $16.00M | $236.00M | (m) | 3.12% | 0.47% | (m) | (m) |
| 2025-06-30 | $113.00M | $3.36B | $14.00M | $268.00M | (m) | 3.37% | 0.42% | (m) | (m) |
| 2025-03-31 | $113.00M | $3.34B | $14.00M | $250.00M | (m) | 3.39% | 0.42% | (m) | (m) |
| 2024-12-31 | $112.00M | $3.40B | $14.00M | $259.00M | (m) | 3.29% | 0.41% | (m) | (m) |
| 2024-09-30 | $110.00M | $3.45B | $14.00M | $289.00M | (m) | 3.19% | 0.41% | (m) | (m) |
| 2024-06-30 | $108.00M | $3.51B | $14.00M | $269.00M | (m) | 3.08% | 0.40% | (m) | (m) |
| 2024-03-31 | $106.00M | $3.53B | $13.00M | $254.00M | (m) | 3.00% | 0.37% | (m) | (m) |
| 2023-12-31 | $108.00M | $3.50B | $10.00M | $241.00M | (m) | 3.09% | 0.29% | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $3.34B | (m) | $305.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $104.00M | $3.35B | $11.00M | $318.00M | (m) | 3.11% | 0.33% | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $132.00M | $3.23B | $11.00M | $174.00M | (m) | 4.09% | 0.34% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PATRICK INDUSTRIES INC (PATK) | United States | $2.176B | 20.75 |
| LCI INDUSTRIES (LCII) | United States | $2.034B | 12.21 |
| VISTEON CORP (VC) | United States | $2.398B | 16.55 |
| DANA Inc (DAN) | United States | $2.944B | 2.63 |
| Adient plc (ADNT) | Ireland | $1.311B | 29.53 |
| Dauch Corp (DCH) | United States | $1.287B | -7.80 |
| Versigent PLC (VGNT) | $3.205B | ||
| Aeva Technologies, Inc. (AEVA) | United States | $1.088B | -60.83 |
| Gentherm Inc (THRM) | United States | $1.040B | 39.43 |
| STANDARD MOTOR PRODUCTS, INC. (SMP) | United States | $0.834B | 17.02 |